These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3221903)

  • 1. Meige syndrome: neuropathology of a case.
    Kulisevsky J; Marti MJ; Ferrer I; Tolosa E
    Mov Disord; 1988; 3(2):170-5. PubMed ID: 3221903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Dilemma: Unraveling Meige Disorder Mistaken for Functional Neurological Disorder.
    Chadha Y; Toshniwal S; Patil R
    Cureus; 2024 May; 16(5):e61465. PubMed ID: 38953076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meige Syndrome as a Craniofacial Type of Dystonia Treatable by Dual Dopaminergic Modulation Using L-DOPA/Chlorpromazine: A Case Report.
    Matsumoto S; Goto S
    J Mov Disord; 2024 Apr; 17(2):233-235. PubMed ID: 38253477
    [No Abstract]   [Full Text] [Related]  

  • 4. Movement disorders of the mouth: a review of the common phenomenologies.
    Ghadery CM; Kalia LV; Connolly BS
    J Neurol; 2022 Nov; 269(11):5812-5830. PubMed ID: 35904592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actin and Diseases of the Nervous System.
    Bernstein BW; Maloney MT; Bamburg JR
    Adv Neurobiol; 2011; 5():201-234. PubMed ID: 35547659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm.
    Vivancos-Matellano F; Rodríguez-Sanz A; Herrero-Infante Y; Mascías-Cadavid J
    Neuroophthalmology; 2019 Nov; 43(5):277-283. PubMed ID: 31741669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Quantitative MRI Reveals No Evidence for Tissue Pathology in Idiopathic Cervical Dystonia.
    Gracien RM; Petrov F; Hok P; van Wijnen A; Maiworm M; Seiler A; Deichmann R; Baudrexel S
    Front Neurol; 2019; 10():914. PubMed ID: 31507518
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropathology of Dystonia.
    Sharma N
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():569. PubMed ID: 30886764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity.
    Simonyan K; Frucht SJ; Blitzer A; Sichani AH; Rumbach AF
    Sci Rep; 2018 Oct; 8(1):16111. PubMed ID: 30382161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia.
    Shakkottai VG; Batla A; Bhatia K; Dauer WT; Dresel C; Niethammer M; Eidelberg D; Raike RS; Smith Y; Jinnah HA; Hess EJ; Meunier S; Hallett M; Fremont R; Khodakhah K; LeDoux MS; Popa T; Gallea C; Lehericy S; Bostan AC; Strick PL
    Cerebellum; 2017 Apr; 16(2):577-594. PubMed ID: 27734238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses.
    Iacono D; Geraci-Erck M; Peng H; Rabin ML; Kurlan R
    Tremor Other Hyperkinet Mov (N Y); 2015; 5():. PubMed ID: 26069855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.
    Pappas SS; Leventhal DK; Albin RL; Dauer WT
    Curr Top Dev Biol; 2014; 109():97-169. PubMed ID: 24947237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings.
    Oblak AL; Hagen MC; Sweadner KJ; Haq I; Whitlow CT; Maldjian JA; Epperson F; Cook JF; Stacy M; Murrell JR; Ozelius LJ; Brashear A; Ghetti B
    Acta Neuropathol; 2014 Jul; 128(1):81-98. PubMed ID: 24803225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary dystonia: moribund or viable.
    Bressman SB; Saunders-Pullman R
    Mov Disord; 2013 Jun; 28(7):906-13. PubMed ID: 23893447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar pathology of a dual clinical diagnosis: patients with essential tremor and dystonia.
    Ma K; Babij R; Cortés E; Vonsattel JP; Louis ED
    Tremor Other Hyperkinet Mov (N Y); 2012; 2():. PubMed ID: 23439731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathological diagnostic considerations in hyperkinetic movement disorders.
    den Dunnen WF
    Front Neurol; 2013; 4():7. PubMed ID: 23420606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the pathology of dystonia.
    Standaert DG
    Neurobiol Dis; 2011 May; 42(2):148-51. PubMed ID: 21220015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brainstem pathology in spasmodic dysphonia.
    Simonyan K; Ludlow CL; Vortmeyer AO
    Laryngoscope; 2010 Jan; 120(1):121-4. PubMed ID: 19795469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study.
    Simonyan K; Tovar-Moll F; Ostuni J; Hallett M; Kalasinsky VF; Lewin-Smith MR; Rushing EJ; Vortmeyer AO; Ludlow CL
    Brain; 2008 Feb; 131(Pt 2):447-59. PubMed ID: 18083751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation of actin and cofilin in identical twins with juvenile-onset dystonia.
    Gearing M; Juncos JL; Procaccio V; Gutekunst CA; Marino-Rodriguez EM; Gyure KA; Ono S; Santoianni R; Krawiecki NS; Wallace DC; Wainer BH
    Ann Neurol; 2002 Oct; 52(4):465-76. PubMed ID: 12325076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.